Related Experiment Video
Updated: Nov 29, 2025

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study
Irina R Gilyazova1, Narasimha M Beeraka2, Elizaveta A Klimentova1
1Institute of Biochemistry and Genetics - Subdivision of the Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa,Russian Federation.
Background:
Renal cell carcinoma represents 3% of all adult malignancies. MicroRNAs exhibit specific functions in various biological processes through their interaction with cellular mRNA involved in apoptosis and cell cycle control. Recent studies have reported the potential association of single-nucleotide polymorphisms (SNPs) in miRNA-binding sites of VHL-HIF1α pathway genes with renal cancer development and progression.
Objective:
The objective of this study is to investigate the SNPs invoking an alteration in the nature of interaction with miRNA binding sites of VHL-HIF1α pathway genes.
Methods:
Total 450 cases of histologically and clinically verified ccRCC and 490 controls were included in our study. Genotyping was performed using a TaqMan PCR allelic discrimination method. Kaplan-Meier method of statistical analysis was implemented to analyze the overall patient survival rate.
Results:
Polymorphism rs10491534 in TSC1 gene was significantly associated with the risk of developing advanced ccRCC. Allele G of rs1642742 in VHL gene was significantly prevalent in ccRCC compared with the control group aged 55 and older (OR = 1.5566; CI [1.1532-2.1019]). Results from the dominant model combining individuals with AG or AA genotype showed that the A allele bearers of CDCP1 rs6773576 exhibited a higher risk of death compared to GG carriers (HR 3.93, 95% CI 1.76-17.21, log-rank P = 0.0033).
Conclusion:
The present study delineated the association of miRNA binding site variants in VHL- HIF1α pathway genes with the ccRCC risk, which may affect the clinical outcomes.
Insights
Single-nucleotide polymorphisms (SNPs) in microRNA binding sites of VHL-HIF1α pathway genes are linked to kidney cancer risk and survival. These genetic variations may influence the development and progression of clear cell renal cell carcinoma (ccRCC).
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Renal cell carcinoma (RCC) accounts for 3% of adult malignancies.
- MicroRNAs (miRNAs) regulate apoptosis and cell cycle control.
- Single-nucleotide polymorphisms (SNPs) in miRNA-binding sites of VHL-HIF1α pathway genes are potentially associated with renal cancer.
Purpose of the Study:
- Investigate SNPs affecting miRNA binding sites in VHL-HIF1α pathway genes.
- Determine the association between these SNPs and clear cell renal cell carcinoma (ccRCC) risk.
- Evaluate the impact of these variants on patient survival.
Main Methods:
- Study included 450 ccRCC cases and 490 controls.
- Genotyping performed using TaqMan PCR allelic discrimination.
- Kaplan-Meier method used for survival analysis.
Main Results:
- Polymorphism rs10491534 in TSC1 gene associated with advanced ccRCC risk.
- VHL gene rs1642742 allele G prevalent in ccRCC patients aged 55+ (OR=1.56).
- CDCP1 rs6773576 allele A associated with higher mortality risk (HR=3.93, P=0.0033).
Conclusions:
- miRNA binding site variants in VHL-HIF1α pathway genes are associated with ccRCC risk.
- These genetic variations may influence ccRCC clinical outcomes and patient survival.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
MicroRNAs
MicroRNAs
Non-LTR Retrotransposons
lncRNA - Long Non-coding RNAs

